Although Pfizer raised its forecast for the vaccine, developed with Germany's BioNTech SE, by $1 billion to $32 billion, the drugmaker caut...

Merck in November said its full trial results showed that molnupiravir lowered the chance of hospitalization or death by about 30% in patie...

Noting its rampant and irrational use of the pill, Balram Bhargava, Director General, Indian Council of Medical Research (ICMR) said that e...

According to one of the conditions, as post marketing surveillance the companies will have to submit periodic safety update reports to the ...

You'll need a prescription first from a doctor or other authorized health worker.

The subject experts committee (SEC), a body under India's drug regulator, will meet on Monday to review the applications for granting appro...

The USFDA also said the drug should be given for whom alternative COVID-19 treatment options authorized by the FDA are not accessible or cl...

Data from Pfizer's clinical trial showed its two-drug antiviral regimen was 90% effective in preventing hospitalizations and deaths in pati...

Final results of Paxlovid demonstrated reduction of hospitalisation or death by 89% among high-risk patients treated within three days of s...

If authorized, Merck's pill would be the first that U.S. patients could take at home to ease symptoms and speed recovery, a major step towa...

The coronavirus is headed to the endemic stage in certain countries, giving these new drugs a potentially huge market, along with the abili...

Pfizer said it will waive royalties on sales in all countries covered by the agreement while COVID-19 remains classified as a Public Health...

The antiviral medications stop the virus from replicating in the body.

Pfizer said it plans to submit interim trial results for its pill, which is given in combination with an older antiviral called ritonavir, ...

The pill was licensed for adults 18 and older who have tested positive for COVID-19 and have at least one risk factor for developing severe...

The pills are meant for people who are sick with COVID but are not in the hospital.

The United States is devoting more than $3 billion to advance the development of antiviral pills for COVID-19, according to an official bri...